Overview

Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve behavior control displayed by persons with traumatic brain injury by assessing effectiveness of treatments for post-TBI irritability and aggression.
Phase:
N/A
Details
Lead Sponsor:
Indiana University
Treatments:
Buspirone